12-111472415-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001372574.1(ATXN2):​c.2525-1673T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.668 in 151,972 control chromosomes in the GnomAD database, including 36,983 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 36983 hom., cov: 31)

Consequence

ATXN2
NM_001372574.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.206

Publications

141 publications found
Variant links:
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN2NM_001372574.1 linkc.2525-1673T>C intron_variant Intron 18 of 24 ENST00000673436.1 NP_001359503.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN2ENST00000673436.1 linkc.2525-1673T>C intron_variant Intron 18 of 24 NM_001372574.1 ENSP00000500925.1 A0A5F9ZI57

Frequencies

GnomAD3 genomes
AF:
0.668
AC:
101382
AN:
151854
Hom.:
36910
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.916
Gnomad AMI
AF:
0.540
Gnomad AMR
AF:
0.703
Gnomad ASJ
AF:
0.328
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.904
Gnomad FIN
AF:
0.573
Gnomad MID
AF:
0.612
Gnomad NFE
AF:
0.501
Gnomad OTH
AF:
0.639
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.668
AC:
101519
AN:
151972
Hom.:
36983
Cov.:
31
AF XY:
0.680
AC XY:
50454
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.916
AC:
37998
AN:
41476
American (AMR)
AF:
0.704
AC:
10739
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.328
AC:
1135
AN:
3460
East Asian (EAS)
AF:
0.998
AC:
5170
AN:
5180
South Asian (SAS)
AF:
0.904
AC:
4346
AN:
4808
European-Finnish (FIN)
AF:
0.573
AC:
6035
AN:
10536
Middle Eastern (MID)
AF:
0.610
AC:
177
AN:
290
European-Non Finnish (NFE)
AF:
0.502
AC:
34075
AN:
67946
Other (OTH)
AF:
0.642
AC:
1354
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1403
2806
4208
5611
7014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.556
Hom.:
102598
Bravo
AF:
0.684
Asia WGS
AF:
0.940
AC:
3267
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
1.3
DANN
Benign
0.51
PhyloP100
0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10774625; hg19: chr12-111910219; API